The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-methyl-5-(1H-pyrazol-3-yl)-2-p-tolylthiazole ID: ALA4756395
Cas Number: 1397224-18-8
PubChem CID: 45588555
Max Phase: Preclinical
Molecular Formula: C14H13N3S
Molecular Weight: 255.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nc(C)c(-c3cc[nH]n3)s2)cc1
Standard InChI: InChI=1S/C14H13N3S/c1-9-3-5-11(6-4-9)14-16-10(2)13(18-14)12-7-8-15-17-12/h3-8H,1-2H3,(H,15,17)
Standard InChI Key: OWUYIJUAGSAJFL-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
23.0337 -18.5914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8353 -18.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1674 -19.5044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9801 -19.4193 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.1504 -18.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4428 -18.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7005 -17.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8867 -17.9377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7203 -18.7393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4314 -19.1451 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.9796 -19.0756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3160 -18.5967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5717 -18.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4897 -19.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1581 -20.2235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8998 -19.8855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7452 -20.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1065 -17.1390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 2 1 0
1 2 1 0
1 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 1 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
9 11 1 0
14 17 1 0
7 18 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 255.35Molecular Weight (Monoisotopic): 255.0830AlogP: 3.82#Rotatable Bonds: 2Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.94CX Basic pKa: 2.00CX LogP: 3.64CX LogD: 3.64Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -1.99
References 1. Lerner C,Jakob-Roetne R,Buettelmann B,Ehler A,Rudolph M,Rodríguez Sarmiento RM. (2016) Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket., 59 (22): [PMID:27685665 ] [10.1021/acs.jmedchem.6b00927 ] 2. Dechering K; Duffey M. (2022) Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum ,using a nano luciferase reporter read-out, [10.6019/CHEMBL4888484 ]